Difficulty: Medium
Average Score: 68%
Practice
Which of the following is a correct combination of expected pharmacological action and therapeutic use of Inhaled anticholinergics like Ipratropium?
Correct answer
A
Rationale
The correct answer is A) Blocks muscarinic receptors of the bronchi, resulting in bronchodilation. Used to treat allergen-induced and exercise-induced bronchospasm.
Rationale:
Ipratropium is an inhaled anticholinergic medication that works by blocking muscarinic receptors in the bronchi, leading to bronchodilation. This action helps to open up the airways, making it easier for the individual to breathe. It is commonly used to treat conditions like allergen-induced and exercise-induced bronchospasm.
Option B is incorrect as it describes a medication that potentiates b2 adrenergic receptors, leading to bronchoconstriction, which is the opposite effect of what is desired in the treatment of respiratory conditions.
Option C is incorrect as it describes a medication that blocks all cholinergic receptors, resulting in bronchostimulation, which is not a therapeutic effect for bronchospasm.
Option D is incorrect as it describes a medication that potentiates bl cholinergic receptors, resulting in hyperpnea, which is not a recognized therapeutic use for Ipratropium.
Educational Context:
Understanding the pharmacological actions of medications is crucial for healthcare professionals to ensure safe and effective treatment for their patients. In the case of inhaled anticholinergics like Ipratropium, knowing that it blocks muscarinic receptors and leads to bronchodilation is essential when managing respiratory conditions such as bronchospasm. This knowledge helps healthcare providers make informed decisions when selecting appropriate pharmacological treatments for their clients across the lifespan.
Rationale:
Ipratropium is an inhaled anticholinergic medication that works by blocking muscarinic receptors in the bronchi, leading to bronchodilation. This action helps to open up the airways, making it easier for the individual to breathe. It is commonly used to treat conditions like allergen-induced and exercise-induced bronchospasm.
Option B is incorrect as it describes a medication that potentiates b2 adrenergic receptors, leading to bronchoconstriction, which is the opposite effect of what is desired in the treatment of respiratory conditions.
Option C is incorrect as it describes a medication that blocks all cholinergic receptors, resulting in bronchostimulation, which is not a therapeutic effect for bronchospasm.
Option D is incorrect as it describes a medication that potentiates bl cholinergic receptors, resulting in hyperpnea, which is not a recognized therapeutic use for Ipratropium.
Educational Context:
Understanding the pharmacological actions of medications is crucial for healthcare professionals to ensure safe and effective treatment for their patients. In the case of inhaled anticholinergics like Ipratropium, knowing that it blocks muscarinic receptors and leads to bronchodilation is essential when managing respiratory conditions such as bronchospasm. This knowledge helps healthcare providers make informed decisions when selecting appropriate pharmacological treatments for their clients across the lifespan.